International Trade Commission April 3, 2018 – Federal Register Recent Federal Regulation Documents

The Commission hereby gives notice of the institution of investigations and commencement of preliminary phase antidumping and countervailing duty investigation Nos. 701-TA-603-605 and 731-TA-1413- 1415 (Preliminary) pursuant to the Tariff Act of 1930 (``the Act'') to determine whether there is a reasonable indication that an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of glycine from China, India, Japan, and Thailand, provided for in subheading 2922.49.43 and 2922.49.80 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value from India, Japan, and Thailand, and alleged to be subsidized by the governments of China, India, and Thailand. Unless the Department of Commerce (``Commerce'') extends the time for initiation, the Commission must reach a preliminary determination in antidumping and countervailing duty investigations in 45 days, or in this case by May 14, 2018. The Commission's views must be transmitted to Commerce within five business days thereafter, or by May 21, 2018.

Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Strontium-Rubidium Radioisotope Infusion Systems, and Components Thereof Including Generators, DN 3303; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.